NEIL3 promotes the carcinogenesis of prostate cancer by activating PI3K/Akt/mTOR signaling
Abstract Prostate cancer (PCa) is one of the most common cancers worldwide. Nei endonuclease VIII-like 3 (NEIL3) plays important roles in diverse cancers. In this study, we found that NEIL3 was overexpressed in PCa tissues and cell lines. NEIL3 over-expression was associated with worse prognostic ou...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-05-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02625-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Abstract Prostate cancer (PCa) is one of the most common cancers worldwide. Nei endonuclease VIII-like 3 (NEIL3) plays important roles in diverse cancers. In this study, we found that NEIL3 was overexpressed in PCa tissues and cell lines. NEIL3 over-expression was associated with worse prognostic outcomes in PCa patients. In vitro, PCa cell proliferation, invasion, and migration could be significantly inhibited with knocking down NEIL3 by inactivating the phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of the rapamycin (mTOR) signaling. Besides, we found that the expression of high-mobility gene group A2 and androgen receptor (AR) were upregulated in PCa tissues, and their expression was decreased in C4-2 cells treated with siNEIL3. Nevertheless, R1881 could enhance si-NEIL3-inhibited PI3K, AKT and mTOR phosphorylation levels in both C4-2 cells and PC-3M. In conclusion, NEIL3 could promote the progression of PCa by activating PI3K/AKT/mTOR signaling in PCa cells. Therefore, these results may provide a potential molecular target for PCa treatment. |
|---|---|
| ISSN: | 2730-6011 |